APPLICATION
ANDA062508
TYPE
ANDA
ORIGINAL APPROVAL
1985-07-11
LATEST ACTION
1998-12-31
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
ERYMAXDiscontinued
ERYTHROMYCIN 2% · SOLUTION · TOPICAL
Approval history
1998-12-31Manufacturing (CMC) · Supplement 8AP
1998-12-28Manufacturing (CMC) · Supplement 10AP
1997-10-03Manufacturing (CMC) · Supplement 7AP
1997-01-31Labeling · Supplement 6AP
1993-05-06Labeling · Supplement 5AP
1985-07-11OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.